Skip to Content

Valcyte (valganciclovir) Disease Interactions

There are 3 disease interactions with Valcyte (valganciclovir):

Major

Valganciclovir (Includes Valcyte) ↔ Hematologic Toxicities

Severe Potential Hazard, Moderate plausibility

Applies to: Pancytopenia, Bone Marrow Depression/Low Blood Counts

Severe leukopenia, neutropenia, anemia, thrombocytopenia, pancytopenia, bone marrow aplasia, and aplastic anemia have been reported in patients treated with valganciclovir. The use of this agent should be avoided if the absolute neutrophil count is less than 500 cells/µL, the platelet count is less than 25,000/µ/L, or the hemoglobin is less than 8 g/dL. Complete blood counts with differential and platelet counts should be performed frequently, especially in patients that developed leukopenia after using a nucleoside analog, or in whom neutrophil counts are less than 1000 cells/µL at the beginning of treatment. Therapy with this agent should be administered with caution in patients with bone marrow depression. Increased monitoring is recommended.

Major

Valganciclovir (Includes Valcyte) ↔ Renal Impairment

Severe Potential Hazard, Moderate plausibility

Applies to: Renal Dysfunction, Dehydration

Acute renal failure has been documented in elderly patients (with or without reduced renal function), patients who receive concomitant nephrotoxic drugs, or inadequately hydrated patients. Adequate hydration, dose reduction and close monitoring of renal function are recommended when using valganciclovir in these patients. The tablet form of valganciclovir should not be used in adult patients on hemodialysis (CrCl less than 10 mL/min).

Moderate

Valganciclovir (Includes Valcyte) ↔ Hepatic Impairment

Moderate Potential Hazard, Moderate plausibility

Applies to: Liver Disease

Monitoring is recommended when using valganciclovir in patients with hepatic impairment as the safety and efficacy of this agent has not been studied in these patients.

Valcyte (valganciclovir) drug Interactions

There are 211 drug interactions with Valcyte (valganciclovir)

Valcyte (valganciclovir) alcohol/food Interactions

There is 1 alcohol/food interaction with Valcyte (valganciclovir)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide